15
total announcements
509079.BO · 15 min delayed
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with total comprehensive income of ₹13,271 lakhs and net profit of ₹512 lakhs. The results have been uploaded on the company's website and stock exchanges' websites.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has released an investor presentation for the quarter ended June 30, 2026, highlighting its Indore facility's progress, including the completion of qualification phases, product permissions, and capacity utilization. The company is on track to achieve its targets and is expanding its capabilities to manufacture long-acting depot products and lipid-based antifungals.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has approved the incorporation of a subsidiary in the Philippines and investment by way of subscription to its equity share capital. The proposed subsidiary will undertake marketing, distribution, and other allied activities in the Philippines, facilitating the expansion of the Company's business and presence in the Philippines.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing revenue of Rs. 26,122.75 lakhs and net profit of Rs. 2,246.02 lakhs. The company has also announced the incorporation of a subsidiary in the Philippines and investment by way of subscription to the equity share capital of the proposed subsidiary.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of ₹2,246.02 lakhs and a revenue of ₹26,122.75 lakhs. The company has also incorporated a subsidiary in the Philippines and made an investment in the equity share capital of the proposed subsidiary. The board of directors has approved the financial results and the incorporation of the subsidiary.
Gufic Biosciences Ltd
Gufic Biosciences Ltd announces its 42nd Annual General Meeting to be held on September 4, 2026, through video conferencing, with e-voting details provided.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has released its Business Responsibility and Sustainability Report for the Financial Year 2025-26, highlighting its commitment to responsible business practices, governance, and sustainability.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced its annual report for the financial year 2025-2026, along with the notice of its 42nd annual general meeting. The company has reported revenue from operations of ₹940.48 crore and EBITDA of ₹137.22 crore for the year 2025-2026.
Gufic Biosciences Ltd
Gufic Biosciences Ltd announces book closure and record date for 42nd Annual General Meeting and payment of final dividend for FY 2025-26.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced the 42nd Annual General Meeting (AGM) to be held on September 04, 2026, through video conferencing. The company will consider adopting audited financial statements for the year ended March 31, 2026, and declare a final dividend of 10%.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has scheduled an Earnings Conference Call for investors/analysts on August 17, 2026, at 04:30 p.m. (IST), to discuss the company's business background, prospects, and financial performance.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has informed BSE that a Board meeting is scheduled on August 14, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced the notice of its 42nd Annual General Meeting to be held on September 4, 2026, through video conferencing. The company has also mentioned a commercial dispute in a court case, Commercial Suit No. 23 of 2026, filed by Learning with Legend Brings BANK OF INDIA against Gufic Biosciences Ltd.
Gufic Biosciences Ltd
Gufic Biosciences Ltd has announced the re-appointment of Mr. Pankaj Jayakumar Gandhi as Whole Time Director for a further term of 5 years, subject to shareholder approval.
Gufic Biosciences Ltd
Gufic Biosciences Ltd's Board of Directors meeting held on July 31, 2026, resulted in the re-appointment of Mr. Pankaj Jayakumar Gandhi as a Whole Time Director for a further term of 5 years, subject to shareholder approval.